Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis

MIKKEL FAURSCHOU, LENE MELLEMKJAER, HENRIK STARKLINT, ANNE-LISE KAMPER, ULRIK TARP, ANNE VOSS and SØREN JACOBSEN
The Journal of Rheumatology November 2011, 38 (11) 2400-2405; DOI: https://doi.org/10.3899/jrheum.110329
MIKKEL FAURSCHOU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mikkelf@dadlnet.dk
LENE MELLEMKJAER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HENRIK STARKLINT
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNE-LISE KAMPER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ULRIK TARP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANNE VOSS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SØREN JACOBSEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Characteristics at time of first renal biopsy for 104 patients diagnosed with lupus nephritis between 1971 and 1995.

    CharacteristicNo.
    Women, n (%)10483 (80)
    Median age at time of biopsy, yrs (IQR)10431 (21–41)
    Median duration of SLE prior to biopsy, yrs (IQR)1040.3 (0.0–3.8)
    Median s-creatinine level, μmol/l (IQR)10498 (79–149)
    Median 24-h urinary protein excretion, g (IQR)101*4.0 (1.5–11.3)
    Median systolic blood pressure, mm Hg (IQR)100*130 (120–150)
    Median diastolic blood pressure, mm Hg (IQR)100*90 (75–95)
    WHO class lupus nephritis, n (%)104
      I (normal glomeruli)1 (1.0)
      II (pure mesangial alterations)18 (17.3)
      III (focal segmental)12 (11.5)
      IV (diffuse proliferative)61 (58.7)
      V (diffuse membranous)10 (9.6)
      VI (advanced sclerosing)2 (1.9)
    Median NIH activity index score (IQR)1045 (2–9)
    Median NIH chronicity index score (IQR)1042 (0–3)
    • ↵* Reduced number of patients due to missing data. IQR: interquartile range; WHO: World Health Organization; NIH: US National Institutes of Health.

    • View popup
    Table 2.

    Ratios of observed to expected events (O:E ratios) for all ischemic heart disease (IHD) diagnoses combined, angina pectoris, myocardial infarction (MI), and other diagnoses listed under the ICD-8/10 block of IHD in a cohort of 104 patients diagnosed with lupus nephritis between 1971 and 1995 and followed throughout 2006.

    Diagnosis (ICD-8/10 code)Observed*O:E Ratio (95% CI)
    IHD (410-410/I20–25)316.8 (4.6–9.7)
      Angina pectoris (413/I20)116.0 (3.0–11)
      MI (410/I21)107.9 (3.8–15)
      Other†106.9 (3.3–13)
    • ↵* Observed number of first-time hospital discharge diagnoses.

    • ↵† ICD-8: 411, 412, 414; ICD-10: I22–I25. ICD: International Classification of Diseases.

    • View popup
    Table 3.

    Ratios of observed to expected events (O:E ratios) for all ischemic heart disease (IHD) diagnoses combined according to age at first renal biopsy, age at IHD event, time from first renal biopsy (latency), calendar-year period of first renal biopsy, and renal status, respectively, in a cohort of 104 patients diagnosed with lupus nephritis between 1971 and 1995 and followed throughout 2006.

    FeatureObserved*O:E Ratio (95% CI)
    Age at first renal biopsy, yrs
      < 311317.1 (9.1–29)
      ≥ 31184.8 (2.8–7.5)
    Age at IHD event, yrs
      < 3000.0 (0.0–142)
      30–391142.3 (21–76)
      40–4988.5 (3.6–17)
      50–5976.0 (2.4–12)
      60+52.3 (0.8–5.5)
    Latency, yrs
      0–477.4 (3.0–15)
      5–9109.5 (4.5–17)
      10–1476.2 (2.5–13)
      15+75.0 (2.0–10)
    Calendar-year period of first renal biopsy
      1971–7934.7 (0.9–14)
      1980–89165.7 (3.3–9.3)
      1990–951210.8 (5.6–19)
    Renal status
      – ESRD245.8 (3.7–8.6)
      + ESRD719.4 (7.8–40)
    • ↵* Observed number of first-time hospital discharge diagnoses. ESRD: Endstage renal disease (as defined in text).

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 38, Issue 11
1 Nov 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis
MIKKEL FAURSCHOU, LENE MELLEMKJAER, HENRIK STARKLINT, ANNE-LISE KAMPER, ULRIK TARP, ANNE VOSS, SØREN JACOBSEN
The Journal of Rheumatology Nov 2011, 38 (11) 2400-2405; DOI: 10.3899/jrheum.110329

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
High Risk of Ischemic Heart Disease in Patients with Lupus Nephritis
MIKKEL FAURSCHOU, LENE MELLEMKJAER, HENRIK STARKLINT, ANNE-LISE KAMPER, ULRIK TARP, ANNE VOSS, SØREN JACOBSEN
The Journal of Rheumatology Nov 2011, 38 (11) 2400-2405; DOI: 10.3899/jrheum.110329
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Vasculitis: What Have We Learned in the Last 50 Years?
  • Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)–associated Bronchiectasis: Role of RA-related Autoantibodies
  • Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Show more Articles

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire